BCM
QDEL icon

BlueCrest Capital Management’s QuidelOrtho QDEL Stock Holding History

BlueCrest Capital Management’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,598
Closed -$601K – 1750
2018
Q1 		$601K Buy
+11,598
New +$540K 0.02% 673

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BlueCrest Capital Management's QDEL Position: Q2 2018 in Review

BlueCrest Capital Management sold out of QuidelOrtho (QDEL) in Q2 2018, closing a stake of 11,598 shares — an estimated $601K sold.

BlueCrest Capital Management first reported a position in QDEL in Q1 2018 and held it in 1 quarter. The position peaked at $601K in Q1 2018. 166 funds tracked by Wall St. Rank hold QDEL as of Q2 2018.

  • BlueCrest Capital Management reported no remaining QuidelOrtho position as of Q2 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 11,598 QuidelOrtho shares in Q2 2018, an estimated $601K.
  • BlueCrest Capital Management first reported a position in QuidelOrtho in Q1 2018 and held it in 1 quarter.
  • BlueCrest Capital Management's QuidelOrtho position peaked at $601K in Q1 2018.
  • 166 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2018.

Based on BlueCrest Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.